The company said in a statement that will no longer advertise compounded GLP-1 offerings on its platform or in its marketing, and existing patients will have the opportunity to transition to FDA-approved medicines when determined clinically appropriate by their providers
Both glucagon and GLP-1 are products of the proglucagon peptide encoded by the preproglucagon gene ( Gcg )
The FDAs approval of GLP-1 medication for weight loss has opened new doors for those seeking effective medications to support their journey towards a healthier weight
This suggests that treatment with arGLP-1 could be particularly beneficial for individuals struggling with suboptimal weight loss outcomes after surgery
Likewise, tirzepatide (Mounjaro), a dual GIP/GLP-1 agonist, has outperformed many comparators in clinical trials, offering additional benefits like improved lipid profiles
Glucagon-like peptide-1 receptor agonist and glucagon increase glucose-stimulated insulin secretion in beta cells via distinct adenylyl cyclases